Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Cytovia raises USD 10 million for development and commercialization of proprietary technology

April 9, 1998

CombiChem and Icos announce drug discovery collaboration

April 9, 1998

Baxter, Inhale select lead compound for further development

April 8, 1998

Targeted Genetics and Copernicus Gene Systems announce collaborative research agreement

April 8, 1998

Transkaryotic Therapies receives patent for Gene Activation technology

April 8, 1998

Targeted Genetics announces collaboration with NHLBI

April 7, 1998

Genetronics' EPT plus bleomycin looks effective in prostate cancer

April 6, 1998

Inhale reports successful phase I and II results with drugs from Baxter collaboration

April 6, 1998

U.S. patent issues for GenVec's advanced gene therapy vectors

April 3, 1998

TAPET efficacy reported at AACR meeting

April 2, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...